Abstract
Chronic subdural hematoma (CSDH) is a frequent pathological entity in daily clinical practice. The incidence is expected to double over the next 30 years, but evidence-based CSDH guidelines are lacking. Currently, surgery is the mainstay in CSDH treatment. Middle meningeal artery embolization and nonsurgical treatments have also been suggested in the management of CSDH. High-quality randomized controlled trials are currently ongoing in order to provide class I evidence on the clinical and cost-effectiveness of (non)surgical treatments.
| Original language | English |
|---|---|
| Title of host publication | Neurosurgical diseases: An evidence-based approach to guide practice |
| Editors | T.L. Lai, Cristian Gragnaniello |
| Place of Publication | New York |
| Publisher | Thieme Medical Publishers |
| Chapter | 15 |
| Pages | 120-127 |
| Number of pages | 8 |
| ISBN (Print) | 978-1684200511 |
| Publication status | Published - 7 Nov 2021 |
Fingerprint
Dive into the research topics of 'Natural history and management options of chronic subdural hematoma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver